Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Articles by John Stagg
PRMT7 restricts CD8+ T cells expansion via the NF-ΚB pathway
Abstract Successful cellular immunotherapy for cancer utilising cytotoxic T lymphocytes (CTL) requires efficient expansion while maintaining effector function. Understanding how CTL expansion and function are regulated during the cell preparation process is thus important. Here, we show that T cell-specific deletion of Prmt7 using CD4-Cre increases CD8+ T cell effector differentiation, cytokine secretion, cytolytic activity and anti-tumor responses.
Neoadjuvant stereotactic body radiation therapy with durvalumab and oleclumab in ER + HER2 − breast cancer: a randomized phase 2 trial
|
Abstract Patients with estrogen receptor-positive (ER+), HER2-negative, early breast cancer (BC) have low pathologic complete response (pCR) rates following neoadjuvant chemotherapy. Immune checkpoint inhibitors (ICIs) provide limited benefit in programmed death-ligand 1 (PD-L1)-negative tumors, characterized by an immune-cold tumor microenvironment.
By Alex De Caluwe, Isabelle Desmoulins, Kim Cao, Vincent Remouchamps, Andrea Garcia, Andrea García, David Venet, Luca Arecco, Elisa Agostinetto, Guilherme Nader-Marta, Zoe Denis, Jennifer Dhont, Paulus Kristanto, Xavier Catteau, Denis Larsimont, Roberto Salgado, Philip Martin Poortmans, John Stagg, Christos Sotiriou, Martine Piccart, Michail Ignatiadis, Emanuela Romano, Laurence Buisseret, Adinda Baten, Eleonore Longton, Karine Peignaux
|
Nature
Verified
The deubiquitinase USP17 regulates the expression and activity of the oncogenic driver β-catenin in colorectal cancer - Oncogene
Abstract Aberrant activation of the Wnt/β-catenin signaling pathway is a hallmark of colorectal cancer (CRC). Here, we identify the deubiquitinating enzyme USP17 as a critical regulator of β-catenin stability and activity in CRC. We demonstrate that USP17 directly interacts with and deubiquitinates β-catenin, preventing its degradation and enhancing its stability.
Author Correction: Paclitaxel plus carboplatin and durvalumab with or without oleclumab for women with previously untreated locally advanced or metastatic triple-negative breast cancer: the randomized SYNERGY phase I/II trial | Nature Communications
Correction to: Nature Communications https://doi.org/10.1038/s41467-023-42744-y, published online 02 November 2023 In the “Discussion” section of the original manuscript, the authors reported information and data related to an unpublished work (Metoikidou C. and colleagues). Considering the confidential nature of these data, it has been decided to remove the related paragraph from the “Discussion” section.
Paclitaxel plus carboplatin and durvalumab with or without oleclumab for women with previously untreated locally advanced or metastatic triple-negative breast cancer: the randomized SYNERGY phase I/II trial | Nature Communications
Abstract Chemo-immunotherapy is the first-line standard of care for patients with PD-L1 positive metastatic triple-negative breast cancer (mTNBC). SYNERGY (NCT03616886) is a dose-finding phase I and a randomized phase II, open-label trial evaluating if targeting the immunosuppressive adenosine pathway can enhance the antitumor activity of chemo-immunotherapy.
Gluten induces rapid reprogramming of natural memory αβ and γδ intraepithelial T cells to induce cytotoxicity in celiac disease
(0)eLetters eLetters is a forum for ongoing peer review. eLetters are not edited, proofread, or indexed, but they are screened. eLetters should provide substantive and scholarly commentary on the article. Embedded figures cannot be submitted, and we discourage the use of figures within eLetters in general. If a figure is essential, please include a link to the figure within the text of the eLetter. Please read our Terms of Service before submitting an eLetter. Log In to Submit a Response
A three-stage developmental pathway for human Vγ9Vδ2 T cells within the postnatal thymus
Editor’s summary Unconventional T cells play an important role in protective immunity; however, the development of these distinctive cell populations is poorly understood. Using tissues donated from children undergoing heart surgery, Perriman et al. investigated the development of Vγ9Vδ2 T cells, a large population of unconventional γδ T cells found in adults, addressing the uncertainty about the role of the postnatal thymus in their maturation.
A three-stage developmental pathway for human Vγ9Vδ2 T cells within the postnatal thymus
Editor’s summary Unconventional T cells play an important role in protective immunity; however, the development of these distinctive cell populations is poorly understood. Using tissues donated from children undergoing heart surgery, Perriman et al. investigated the development of Vγ9Vδ2 T cells, a large population of unconventional γδ T cells found in adults, addressing the uncertainty about the role of the postnatal thymus in their maturation.
3D chromatin reprogramming primes human memory TH2 cells for rapid recall and pathogenic dysfunction
Editor’s summary Long-lived memory T cells provide immunological protection by rapidly responding upon antigen re-encounter, but they can also contribute to disease by causing excessive inflammation. Using multi-scale epigenomics, Onrust-van Schoonhoven et al. examined how the three-dimensional organization of chromatin facilitates rapid recall of human memory T helper 2 (TH2) cells.
The interplay between the DNA damage response and ectonucleotidases modulates tumor response to therapy
Abstract The extracellular nucleoside adenosine reduces tissue inflammation and is generated by irreversible dephosphorylation of adenosine monophosphate (AMP) mediated by the ectonucleotidase CD73.
Restoring tumor immunogenicity with dendritic cell reprogramming
Editor’s summary Cancer cells down-regulate antigen presentation to evade recognition by the immune system. Zimmermannova et al. investigated the ability to reprogram cancer cells into tumor-derived antigen-presenting cells (tumor-APCs).
TCRward personalized transplant therapies
(0)eLetters eLetters is a forum for ongoing peer review. eLetters are not edited, proofread, or indexed, but they are screened. eLetters should provide substantive and scholarly commentary on the article. Embedded figures cannot be submitted, and we discourage the use of figures within eLetters in general. If a figure is essential, please include a link to the figure within the text of the eLetter. Please read our Terms of Service before submitting an eLetter. Log In to Submit a Response
TCRward personalized transplant therapies
(0)eLetters eLetters is a forum for ongoing peer review. eLetters are not edited, proofread, or indexed, but they are screened. eLetters should provide substantive and scholarly commentary on the article. Embedded figures cannot be submitted, and we discourage the use of figures within eLetters in general. If a figure is essential, please include a link to the figure within the text of the eLetter. Please read our Terms of Service before submitting an eLetter. Log In to Submit a Response
Fueling the fire of B cell activation
(0)eLetters eLetters is a forum for ongoing peer review. eLetters are not edited, proofread, or indexed, but they are screened. eLetters should provide substantive and scholarly commentary on the article. Embedded figures cannot be submitted, and we discourage the use of figures within eLetters in general. If a figure is essential, please include a link to the figure within the text of the eLetter. Please read our Terms of Service before submitting an eLetter. Log In to Submit a Response
3D chromatin reprogramming primes human memory TH2 cells for rapid recall and pathogenic dysfunction
Editor’s summary Long-lived memory T cells provide immunological protection by rapidly responding upon antigen re-encounter, but they can also contribute to disease by causing excessive inflammation. Using multi-scale epigenomics, Onrust-van Schoonhoven et al. examined how the three-dimensional organization of chromatin facilitates rapid recall of human memory T helper 2 (TH2) cells.
Restoring tumor immunogenicity with dendritic cell reprogramming
Editor’s summary Cancer cells down-regulate antigen presentation to evade recognition by the immune system. Zimmermannova et al. investigated the ability to reprogram cancer cells into tumor-derived antigen-presenting cells (tumor-APCs).
The interplay between the DNA damage response and ectonucleotidases modulates tumor response to therapy
Abstract The extracellular nucleoside adenosine reduces tissue inflammation and is generated by irreversible dephosphorylation of adenosine monophosphate (AMP) mediated by the ectonucleotidase CD73.
Publisher Correction: The adenosine pathway in immuno-oncology
Nature Reviews Clinical Oncology (2020) https://doi.org/10.1038/s41571-020-0382-2 Published online 08 June 2020 The originally published article contained an error in Table 1, in which oleclumab was incorrectly described as an anti-CD79 monoclonal antibody (mAb) instead of an anti-CD73 mAb. This editorial error has been corrected in the HTML and PDF versions of the manuscript to reflect that oleclumab in an anti-CD73 mAb. Author information Affiliations Institut du Cancer de Montréal, Centre...
It’s Our Time
Instead of Time Magazine creating the phony scenario of a crying little girl looking up at Trump on the cover, a Democrat donkey would have been a much better fit. Did you enjoy this cartoon? And, please consider support for the Second Front in Defense of the Second Amendment: A.F. Branco is a GrassRoots Conservative Political Cartoonist for Conservative Daily News, Net Right Daily, Legal Insurrection, and now Ammoland Shooting Sports News.
CD73-A2a adenosine receptor axis promotes innate B cell antibody responses to pneumococcal polysaccharide vaccination
Many individuals at risk of streptococcal infection respond poorly to the pneumococcal polysaccharide vaccine Pneumovax 23. Identification of actionable pathways able to enhance Pneumovax responsiveness is highly relevant. We investigated the contribution of the extracellular adenosine pathway regulated by the ecto-nucleotidase CD73 in Pneumovax-induced antibody responses.
Immunotherapeutic approaches in triple-negative breast cancer: latest research and clinical prospects
Triple-negative breast cancer (TNBC), as defined by the absence of estrogen receptor, progesterone receptor and human epidermal growth factor receptor 2 expression, is a challenging disease with the poorest prognosis of all breast cancer subtypes. Importantly, there are currently no known molecular targets for this subgroup of patients. Recent advances in genomics and gene expression profiling have shed new light on the molecule heterogeneity of TNBC.
Show More
loading
Actions
Is this you?
As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.Get in touch with John
Contact John, search articles and posts on X, monitor coverage, and track replies from one place.
Learn more about Muck Rack